Clin2
NCT07736911Possibly a fitRecruiting

Should you pause your diabetes medication before a stomach scope?

GLP-1

Part of Digestive system, Hormones & metabolism clinical trials.

This trial is testing whether stopping GLP-1 receptor agonists or tirzepatide one week before an upper endoscopy (a scope that looks at your stomach and esophagus) is safe and effective. It's designed for people who are already taking these medications and have an upcoming procedure.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
140 people
Ages
18 years to 90 years
Study type
Interventional

Who can take part

  • You are currently taking a GLP-1 receptor agonist or tirzepatide.
  • You have been on this medication for at least 4 weeks or are on a high maintenance dose.
  • You are between 18 and 70 years old.
  • You are scheduled for an upper endoscopy (EGD) for any reason.
  • You are able to stop certain medicines that affect stomach movement at least 3 days before the procedure.
  • You do not have severe health problems that would make the endoscopy risky (like heart issues or liver cirrhosis).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07736963Recruiting
Stopping GLP-1 drugs before colonoscopy: a trial in Taiwan

This study looks at whether stopping GLP-1 receptor agonists (a type of diabetes or weight-loss medication) before a colonoscopy can help improve the procedure. It compares how well the bowel is cleaned in people who stop these drugs for a certain time versus those who continue them.

New Taipei, Taiwan
NCT07127354Recruiting· Phase 4
GLP-1 medications and colonoscopy prep quality

This study tests whether a special bowel preparation plan works better for people taking GLP-1 or GIP medications (like Ozempic, Mounjaro) before a colonoscopy. It aims to improve the quality of the bowel cleaning so doctors can see the colon more clearly.

Cleveland, Florida
NCT06734312Recruiting
Stomach procedure to maintain weight loss after GLP-1s

This study is for people who have lost weight using semaglutide or tirzepatide and are stopping that medication. It tests a stomach procedure (called mucosal ablation) to see if it can help you keep the weight off after stopping the drug.

Cary, North Carolina
NCT07276763Not yet recruiting
Stopping GLP-1 drugs before endoscopy to prevent stomach delay

This study looks at whether pausing GLP-1 agonist medications (like Ozempic or Trulicity) for two weeks before an upper endoscopy can reduce the chance of food staying in the stomach during the procedure. It may help people who take these diabetes medicines and need a routine endoscopy.

Shanghai, Shanghai Municipality
NCT07152756Not yet recruiting
Stopping semaglutide for one week before endoscopy

This study checks if stopping semaglutide (a diabetes/weight-loss drug) for one week before a sedated endoscopy helps reduce leftover food in the stomach and improves how well doctors can see the stomach lining. It may help patients who need a clear view during the procedure.

Shanghai, Shanghai Municipality
NCT06839248Recruiting
Fasting before procedures with GLP-1 meds

This study looks at whether people taking weekly GLP-1 medications (like Ozempic or Wegovy) should follow standard fasting rules or a 24-hour clear liquid diet before a procedure. The goal is to find the safest way to prepare.

Melbourne, Victoria

Hear when a new GLP-1 trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.